Literature DB >> 12746601

[Bacterial contamination: epidemiology in cataract surgery].

J Feys1, J-P Emond, A Salvanet-Bouccara, A Dublanchet.   

Abstract

PURPOSE: To evaluate anterior chamber (AC) bacterial contamination at the end of cataract surgery in a large series of patients, to determine the influence of operative technique on ocular contamination.
METHODS: Retrospective study of 2,624 patients undergoing cataract extraction, 354 extracapsular cataract extraction (ECCE) and 2,270 phacoemulsification. Anterior chamber aspirates were performed on completion of surgery for microbiological studies.
RESULTS: One hundred and thirty two patients (5%) had culture-positive anterior chamber aspirates. Coagulase-negative Staphylococcus, Propionibacterium sp. and Corynebacterium sp. were the most commonly isolated organisms. The AC contamination rates during ECCE (5.6%) and phacoemulsification (4.7%) were not statistically different. There was a statistically significantly higher risk of AC contamination in eyes receiving an intraocular lens (IOL) with polypropylene haptics (9.9%) than in eyes receiving the same IOL with polymethylmethacrylate haptics (4.4%).
CONCLUSION: Surgical technique had no statistically significant effect on ocular contamination. Polypropylene haptics IOLs were associated with a higher risk of bacterial contamination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746601

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  2 in total

1.  Effects of bacterial adhesion with respect to the type of material, structure and design of intraocular lenses.

Authors:  J I Alava; N Garagorri; N Briz; J Mendicute
Journal:  J Mater Sci Mater Med       Date:  2005-04       Impact factor: 3.896

2.  Comparison of different techniques of cataract surgery in bacterial contamination of the anterior chamber in diabetic and non-diabetic population.

Authors:  M Ashok Kumar; Sheen S Kurien; Stephen Selvaraj; Uma Devi; S Selvasundari
Journal:  Indian J Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.